Matches in Wikidata for { <http://www.wikidata.org/entity/Q86124086> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q86124086 description "artículu científicu espublizáu n'ochobre de 2014" @default.
- Q86124086 description "scientific article published on 02 October 2014" @default.
- Q86124086 description "wetenschappelijk artikel" @default.
- Q86124086 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q86124086 name "The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial" @default.
- Q86124086 name "The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial" @default.
- Q86124086 type Item @default.
- Q86124086 label "The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial" @default.
- Q86124086 label "The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial" @default.
- Q86124086 prefLabel "The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial" @default.
- Q86124086 prefLabel "The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial" @default.
- Q86124086 P1433 Q86124086-A4FA2E3D-9C61-4AB5-AF92-3E045E1A84F8 @default.
- Q86124086 P1476 Q86124086-7CAD8CC9-46D6-49CF-92B1-3CB635B20EDC @default.
- Q86124086 P2093 Q86124086-2BC1E1AF-80B2-47E9-8474-13D11CE6D42D @default.
- Q86124086 P2093 Q86124086-2E7AD018-F25D-43B8-8072-A10E21CF878A @default.
- Q86124086 P2093 Q86124086-3155B6CA-1CEB-4845-9441-7B84EC5893B7 @default.
- Q86124086 P2093 Q86124086-87C266D4-C668-4C77-BF4F-2A9D2EB84739 @default.
- Q86124086 P2093 Q86124086-A3BB532B-223F-49A1-AA36-6629C1FD02B1 @default.
- Q86124086 P2093 Q86124086-B6FBF48F-8C04-47AB-B057-C8BB03E45154 @default.
- Q86124086 P2093 Q86124086-B718FC84-90DD-4F6F-AECE-1BEBC38FAE09 @default.
- Q86124086 P2093 Q86124086-E93ECF01-51C1-4EC6-9C6E-9BB6C99AA222 @default.
- Q86124086 P304 Q86124086-AF2DEA55-B1DB-46DB-A41F-38A22A24014C @default.
- Q86124086 P31 Q86124086-AF4B8E00-657C-4F79-A9CA-8F50D8534B1F @default.
- Q86124086 P356 Q86124086-78E1AF7B-A3A8-4B9B-9E8A-16DC08EC1D47 @default.
- Q86124086 P433 Q86124086-2599E1C2-F691-45A6-ADEE-BD415CA2389F @default.
- Q86124086 P478 Q86124086-3DFEF6FD-B313-4114-84DC-7257E490DB67 @default.
- Q86124086 P577 Q86124086-BEDE8FC9-C4DE-4EA7-A389-2345DFAEFDD0 @default.
- Q86124086 P698 Q86124086-3B926FDE-B82E-41E8-B307-12D7FBD92738 @default.
- Q86124086 P921 Q86124086-857B1B73-5F53-4DB3-8D11-A73B4CA9EEFE @default.
- Q86124086 P921 Q86124086-F088A59A-4DE0-4B6C-A0DB-3B5064FBFF40 @default.
- Q86124086 P356 J.CLBC.2014.09.010 @default.
- Q86124086 P698 25454688 @default.
- Q86124086 P1433 Q332245 @default.
- Q86124086 P1476 "The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial" @default.
- Q86124086 P2093 "Akiko Emi" @default.
- Q86124086 P2093 "Hideo Shigematsu" @default.
- Q86124086 P2093 "Keiko Kajitani" @default.
- Q86124086 P2093 "Masahiro Ohara" @default.
- Q86124086 P2093 "Morihito Okada" @default.
- Q86124086 P2093 "Norio Masumoto" @default.
- Q86124086 P2093 "Takayuki Kadoya" @default.
- Q86124086 P2093 "Tatsunari Sasada" @default.
- Q86124086 P304 "110-116" @default.
- Q86124086 P31 Q13442814 @default.
- Q86124086 P356 "10.1016/J.CLBC.2014.09.010" @default.
- Q86124086 P433 "2" @default.
- Q86124086 P478 "15" @default.
- Q86124086 P577 "2014-10-02T00:00:00Z" @default.
- Q86124086 P698 "25454688" @default.
- Q86124086 P921 Q238512 @default.
- Q86124086 P921 Q6934595 @default.